Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial.

Horn, Michael; Behre, Ulrich; Traskine, Magali; Dobbelaere, Kurt; Borys, Dorota

Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial.

Horn, Michael; Behre, Ulrich; Traskine, Magali; Dobbelaere, Kurt; Borys, Dorota.

Afiliación

Horn M; Pediatric Office, Schönau Am Königssee, Germany.
Behre U; Private Practice, Kehl, Germany.
Traskine M; HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.
Dobbelaere K; HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.
Borys D; HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.

Hum Vaccin Immunother ; 17(5): 1463-1469, 2021 05 04.

Article en En | MEDLINE | ID: mdl-33175600

Asunto(s)

Haemophilus influenzae; Infecciones Neumocócicas; Anticuerpos Antibacterianos; Preescolar; Alemania; Humanos; Inmunogenicidad Vacunal; Lactante; Vacunas Neumococicas; Vacunas Conjugadas

Palabras clave

PHiD-CV; Pneumococcal conjugate vaccine; booster dose; immunogenicity; safety; toddlers

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Haemophilus influenzae Tipo de estudio: Clinical_trials Límite: Child, preschool / Humans / Infant País/Región como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google